#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neoplasm malignant Neurodegenerative disorder Testicular leiomyosarcoma Arteriovenous malformation Round cell liposarcoma Hereditary optic atrophy Autoimmune myositis Acute hepatic failure Synovial sarcoma Chronic lymphocytic leukaemia recurrent Extraskeletal ossification Arginase deficiency Pulmonary hypertension Tourette's disorder Chronic graft versus host disease in intestine More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Life with Disease Short-bowel syndrome – Trials in Disease Adrenogenital syndrome Primary hyperoxaluria Angiosarcoma – Treatment Synovial sarcoma metastatic – Life with Disease Congenital hypotransferrinaemia – Treatment Antisynthetase syndrome – Life with Disease Marginal zone lymphoma refractory – Basic Information Myelodysplastic syndrome with excess blasts – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RIMIDUCID N-Acetylhistidine Cimetidine AZD4512 Polatuzumab Vedotin Mycophenolic Acid Betula Alba Pollen Extract Sym025 Vidofludimus Calcium Gad20-209-Fsp-A4 Hct116-B Clonidine Hydrochloride Ivonescimab Lasofoxifene Methylprednisolone Aceponate Nadroparin Calcium Murcidencel Cannabidiol Guselkumab Pemafibrate More therapies…

    Learn about Your Condition

    Aortic valve disease Inguinal hernia Lymphoma Carotid artery stenosis Anaemia of chronic disease Ventricular extrasystoles Adenomatous polyposis coli Angiosarcoma metastatic Dyspnoea Anaplastic thyroid cancer Growth hormone deficiency Pituitary tumour benign Malignant peritoneal neoplasm Cardiac arrest Osteosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Linezolid
    • Piperacillin Sodium
    • Tazobactam Sodium
    Denmark Sweden

  • Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Efanesoctocog Alfa
    Bulgaria France Germany Greece Italy The Netherlands +4

  • Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • Tretinoin
    • Clindamycin
    Germany

  • Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer recurrent
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    Belgium The Netherlands Norway Portugal Sweden

  • Study Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    • Ustekinumab
    Poland

  • Study on 68Ga-FAPI-46 for Predicting Treatment Response in Early-Stage High-Risk Triple-Negative Breast Cancer Patients Undergoing Chemo-Immunotherapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Doxorubicin Hydrochloride
    France
Previous Page
1 … 466 467 468 469 470 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!